Bioblast Pharma Ltd. _________ Class A Units Consisting of One Ordinary Share and One Series A Warrant to Purchase 0.75 of an Ordinary Share __________ Class B Units Consisting of One Pre-Funded Series B Warrant to Purchase One Ordinary Share and One...Underwriting Agreement • April 5th, 2017 • Bioblast Pharma Ltd. • Pharmaceutical preparations • New York
Bioblast Pharma Ltd., a corporation incorporated under the laws of the State of Israel (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of Bioblast Pharma Ltd., the “Company”), proposes, subject to the terms and conditions contained herein, to sell to you and the other underwriters named in Schedule 1 to this Agreement (the “Underwriters”), for whom you are acting as Representative (the “Representative”), an aggregate of (a) ________ Class A Units (the “Firm Class A Units”), with each Firm Class A Unit consisting of (i) one Company ordinary share (each a “Firm Share”), par value NIS 0.01 per share (the “Ordinary Shares”) and (ii) one Series A Warrant (each a “Series A Warrant”), each warrant to purchase [0.75] of an Ordinary Share at an exercise price of $[___]1 per share and (b) _______ Class B Units (the “Firm Class B Units”)
SERIES A WARRANT TO PURCHASE ORDINARY SHARES bioblast pharma ltd.Bioblast Pharma Ltd. • April 5th, 2017 • Pharmaceutical preparations • New York
THIS SERIES A WARRANT TO PURCHASE ORDINARY SHARES (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 PM New York City time on ___, 202_ (the “Termination Date”) but not thereafter, to subscribe for and purchase from Bioblast Pharma Ltd., an Israeli corporation (the “Company”), up to ______ Ordinary Shares, NIS 0.01 par value (the “Ordinary Share(s)”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
